CClinicalTrials.gg
Status unknownNCT04983290W-DomusUpdated Sep 28, 2021

Outcomes to the Nutritional Need of Patients With Parkinson's Disease

An interventional study of weancare-domus in Deglutition Disorders, Parkinson Disease and Nursing, sponsored by Milko Zanini. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-09-28.

Sponsored by Milko Zanini · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The intervention involves the identification of 140 patients (70 per group), fed throughout the duration of the study with the two different solutions indicated. The subject will be interviewed by identified and trained personnel in order to collect the information and data required by the study with frequency indicated for the individual evaluation sheets. The subject himself will be provided with all the contact and availability information of the referents of the firm for the purpose of requesting information or reporting events. The subject in the studio will be contacted weekly in order to evaluate the trend by the study referents, according to his availability, and personally interviewed by staff belonging to the research group.

Read the detailed description

Non-motor symptomatology in Parkinson's disease (PD) is related to the quality of life of patients . Malnutrition in the subject with Parkinson's is a still relevant variable that hesitates in sarcopenia and increased motor deficits in relation to loss of muscle mass and energy deficit. Guidelines from the European Society for Clinical Nutrition and Metabolism (ESPEN) recommend monitoring and implementing interventions in the presence of weight loss or body mass.

Disphagia is a syndrome common in Parkinson's patients, even in the early stages of the pathology. The study by Pflug and collaborators showed that only 5% of the patients observed were completely free from swallowing deficiency, while in 55% of subjects (66/119) aspiration or penetration of food and liquids in the airways were reported regardless of the stage of illness. Several studies, cited by Curtis and collaborators, show that the prevalence of disphagia varies between 11 and 97% of patients during the course of the disease. This condition affects both food safety, with the risk of aspiration and ab-ingestis, and malnutrition conditions, hydration deficiency, also affecting the overall survival of patients in relation to the onset of pneumonia.

From a nursing point of view, great interest has the integrated nutritional indices, easy and quick-to-use tools, which manage to determine promptly the presence and risk of malnutrition and which can be used daily in the patient's evaluation. The most suitable is the Mini Nutritional Assessment (MNA), which determines the risk of malnutrition before modification of biochemical parameters. MNA has a sensitivity of 96% and a specificity of 97%.

The adoption of scales that evaluate non-motorcycle-related symptoms helps to identify the sindromic dimension of the pathology, highlighting its components that impact the overall quality of life.

Patients who follow a level 3 and 4 modified texture diet of the IDDSI Framework scheme frequently encounter an overall reduction in energy and protein intake, determined by the way the meal is prepared in self-production, associated with an often drastic reduction in fluid intake with consequences in both systemic and specific terms for the gastrointestinal tract. Monitoring liquids introduced by subjects with swallowing deficiency is a Grade B recommendation in the ESPEN guidelines.

Disphagia is a frequent condition in the subject with Parkinson's disease, particularly in the advanced stages, recent studies begin to show a decay in the safety of swallowing and maintenance in the airway in these subjects, even in relatively early stages of the disease.

Therefore, the application of a specific nutritional program for patients with swallowing problems is recommended in the prevention of malnutrition in patients with Parkinson's disease. Previous studies showed the rapid reversibility of malnutrition in hospitalized elderly subjects with cognitive and functional impairment if enrolled in a specific nutritional program.

In view of the strong impact that eating difficulties have on the state of health of parkinson's disease patients suffering from disphagia, the widespread spread of dietary frailties related to the various degrees of disphagia and the importance that patients with slight difficulty swallowing or chewing do not develop further pathologies related to a nutritional deficit , it is necessary to study the effectiveness of specific nutritional programs developed to meet the person's need for nutrition The aim of the study is to improve the nursing-care management of Parkinson's disease patients with disphagia

02

Conditions studied

  • Deglutition Disorders
  • Parkinson Disease
  • Nursing
  • Quality of Life
03

In context

Deglutition Disorders

710 studies on the registry are indexed under Deglutition Disorders; 219 are open to participants now.

This study's planned enrollment of 140 is above the median of 60 across 471 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

This is the only study on the registry with Milko Zanini as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • clinical diagnosis of FOIS-based disphagy or Smithard test (3 oz swallow test) (2 - 3) or previous FEES diagnosis
  • classification of the functional oral intake scale (FOIS) level of disphagy in classes 4 or 5 (or levels 2-3 on specific clinical indication)
  • Belonging to one of the territorial structures for the Management of Parkinson's Disease in the territory of Genoa

Exclusion criteria

Exclusion Criteria:

  • Terminally ill subjects for pathology
  • Subjects with severe disphagia and indication to artificial nutrition (enteral/parenteral)
  • Severe renal, liver and respiratory failure
  • Disphagy level classifications inconsistent with inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    intervention

    The participating subjects belonging to the experimental group, will receive at home a set of foods with modified textures that allow the patient to feed for the observation period of 4 months, will also be followed by the dietary service of the center and by personnel identified within the protocol in order to verify compliance, liability and information regarding the evaluation scales involved in the project.

    Dietary Supplement: weancare-domus

  • No intervention
    control

    The control group will continue with its own feeding for the entire observation period of the experimental group.

Interventions

  • Dietary supplementweancare-domus

    Participants belonging to the experimental group will receive at home a set of foods that allows to receive the right amount of proteins and energy in a modified texture form to be prepared by themselves or by their caregivers

06

What researchers measure

Primary outcomes

  1. Non-motor symptomatology change (Novel Non-Motor Symptoms Scale for Parkinson's Disease - NNMS)

    Novel Non-Motor Symptoms Scale for Parkinson's Disease includes 9 domains and 30 items. Each symptom scored with respect to: Severity: 0 = None, 1 = Mild: symptoms present but causes little distress or disturbance to patient; 2 = Moderate: some distress or disturbance to patient; 3 = Severe: major source of distress or disturbance to patient. Frequency: 1 = Rarely (\<1/wk); 2 = Often (1/wk); 3 = Frequent (several times per week); 4 = Very Frequent (daily or all the time).

    Time frame: 4 months

Secondary outcomes

  1. Suction and ab-ingestis events related to textured food change (Novel Non-Motor Symptoms Scale for Parkinson's Disease - Domain 6: Gastrointestinal tract)

    Novel Non-Motor Symptoms Scale for Parkinson's Disease - Domain 6: Gastrointestinal tract includes 3 items. Each symptom scored with respect to: Severity: 0 = None, 1 = Mild: symptoms present but causes little distress or disturbance to patient; 2 = Moderate: some distress or disturbance to patient; 3 = Severe: major source of distress or disturbance to patient. Frequency: 1 = Rarely (\<1/wk); 2 = Often (1/wk); 3 = Frequent (several times per week); 4 = Very Frequent (daily or all the time). 19. Does the patient dribble saliva during the day? 20. Does the patient have difficulty swallowing? 21. Does the patient suffer from constipation? (Bowel action less than three times weekly)

    Time frame: 4 months

Other outcomes

  1. functional parameter related to malnutrition change: Gait speed

    Gait speed in metres per second (m/s): the fastest gait speed in 4 metres after 3 trials was recorded. Patients may use an assistive device, if needed.

    Time frame: 4 months

  2. functional parameter related to malnutrition change: grip strength

    grip strength of the hand in kg: Handgrip strength will assess using a hydraulic dynamometer. The participant will be seated, resting his or her arm on the chair arms and instructed to squeeze the dynamometer as hard as possible, with the highest score of the 3 trials recorded

    Time frame: 4 months

  3. functional parameter related to malnutrition change: muscle mass

    muscle mass index (%) will be evaluate by Bioelectrical Impedance Analysis (BIA)

    Time frame: 4 months

  4. functional parameter related to malnutrition change: Body Mass Index (BMI)

    weight in kg, height in cm (weight and height will be combined to report BMI in Kg/m\^2)

    Time frame: 4 months

  5. functional parameter related to malnutrition change: arm circumference

    arm circumference in cm

    Time frame: 4 months

  6. functional parameter related to malnutrition change: biomarkers

    plasma cholinesterase concentration (U/ml)

    Time frame: 4 months

  7. functional parameter related to malnutrition change: biomarkers

    plasma transferrin concentration (mg/dL)

    Time frame: 4 months

  8. functional parameter related to malnutrition change: biomarkers

    plasma albumin concentration (g/dL)

    Time frame: 4 months

  9. functional parameter related to malnutrition change: immunological indices

    lymphocyte count in 1 microliter (µL) of blood

    Time frame: 4 months

  10. functional parameter related to malnutrition change: Nutritional status evaluation

    • phase angle and derived body composition data: Phase angle is a linear method of measuring the relationship between electric resistance (R) and reactance (Rc) in series or parallel circuits. It reflects cellular vitality and integrity, where normal values indicate preserved cellular activity. It is an important tool in assessing nutritional status in any situation, being superior to anthropometric and biochemical methods.

    Time frame: 4 months

  11. functional parameter related to malnutrition change: Nutritional status evaluation - MNA score

    Mini Nutritional Assessment Score (MNA):Mini Nutritional Assessment score (MNA) is probably the most widely used and best validated score in different elderly populations and settings. The tool consists of a 6-item short form screening tool (MNA-SF) included in the 18-item long form scale (MNA-LF). From 24 to 30 points: Normal nutritional status; from 17 to 23.5 points: At risk of malnutrition; Less than 17 points: Malnourished

    Time frame: 4 months

  12. functional parameter related to malnutrition change: Bolus transit time evaluation

    time of complete capture of the bolus and the reflex firing of swallowing in minutes

    Time frame: 4 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04983290
Lead sponsor
Milko Zanini
Collaborators
Azienda Sanitaria Locale 3 Genovese
Responsible party
Milko Zanini (assistant professor, University of Genova) — Sponsor-investigator
First posted
Jul 30, 2021
Start date
Nov 1, 2021 (estimated)
Primary completion
Dec 31, 2021 (estimated)
Completion
May 30, 2022 (estimated)
Last update
Sep 28, 2021

Study contacts

Annamaria Bagnasco, Prof
Contact
annamaria.bagnasco@unige.it
+3901035385
Milko Zanini, Dr
Contact
milko.zanini@edu.unige.it
+3901035385
Marina Simonini, Dr
principal investigator · Asl 3 genovese

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion